References
- Rotermann M, Sanmartin C, Hennessy D, Arthur M. Prescription medication use by Canadians aged 6 to 79. Heal Reports. 2014;26(06) https://www150.statcan.gc.ca/n1/pub/82-003-x/2014006/article/14032-eng.htm. Accessed 18 Apr 2019.
- Canadian Institute for Health Information (CIHI). Adverse drug reaction–related hospitalizations among seniors, 2006 to 2011.; 2013. https://secure.cihi.ca/free_products/Hospitalizations for ADR-ENweb.pdf. Accessed 24 Feb 2019.
- TELUS Health. PS Suite EMR User Guide v5.8.; 2017. https://www.hamiltonfht.ca/Modules/DocuShare/Services/DocuShare.ashx?method=GetFile&args[file][authToken]=&args[file][path]=File-99701&args[file][filename]=TelusPS.pdf. Accessed 28 June 2020.
- TELUS Health. Kroll Windows 10 User Manual. Windows 10. 2018.
- Hussein T. Exploring the requisites and design requirements for adding reason for use information to prescription labels. 2018. http://hdl.handle.net/10012/13965.
- Garada M, McLachlan AJ, Schiff GD, Lehnbom EC. What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: a qualitative study. BMC Health Serv Res. 2017;17(1):734. https://doi.org/10.1186/s12913-017-2704-3.
- Mercer K. Communicating health information in primary care: a multidisciplinary exploration of patient, pharmacist, and physician decision-making. 2019. http://hdl.handle.net/10012/14782.
- Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff. 2007;26(3):731–740. https://doi.org/10.1377/hlthaff.26.3.731
- Kobue B, Moch S, Watermeyer J. “It’s so hard taking pills when you don’t know what they’re for”: a qualitative study of patients’ medicine taking behaviours and conceptualisation of medicines in the context of rheumatoid arthritis. BMC Health Serv Res. 2017;17(1):303. https://doi.org/10.1186/s12913-017-2246-8.
- Whaley C. Perspectives from pharmacists, prescribers and patients on sharing medication reason for use. 2020. http://hdl.handle.net/10012/15817.
- Kennedy AG, Benjamin L, Callas PW, Carney JK. Evaluation of a modified prescription form to address prescribing errors. Am J Heal Pharm. 2011;68(2):151–157. https://doi.org/10.2146/ajhp100063.
- Shrank W, Avorn J, Rolon C, Shekelle P. Medication safety: effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review. Ann Pharmacother. 2007;41(5):783–801. https://doi.org/10.1345/aph.1H582.
- Wolf MS, Davis TC, Curtis LM, et al. A patient-centered prescription drug label to promote appropriate medication use and adherence. J Gen Intern Med. 2016;31(12):1482–1489. https://doi.org/10.1007/s11606-016-3816-x.
- Guest G, Bunce A, Johnson L. How many interviews are enough? Field methods. 2006;18(1):59–82. https://doi.org/10.1177/1525822x05279903.
- Weller SC, Vickers B, Bernard HR, et al. Open-ended interview questions and saturation. PLoS One. 2018;13(6):e0198606. https://doi.org/10.1371/journal.pone.0198606.
- Charmaz K. Constructing grounded theory. London: Sage; 2014.
- NVivo qualitative data analysis software. Burlington: QSR International Pty Ltd; 2018.
- Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–1907. https://doi.org/10.1007/s11135-017-0574-8.
- O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9) https://journals.lww.com/academicmedicine/Fulltext/2014/09000/Standards_for_Reporting_Qualitative_Research__A.21.aspx. Accessed 29 July 2019.
- Casares Li R, Hussein T, Bancsi A, Grindrod K, Burns C. Reason for use: an opportunity to improve patient safety. Stud Health Technol Inform. 2019;257:47–52. http://europepmc.org/abstract/MED/30741171.
- Kron K, Myers S, Volk L, et al. Incorporating medication indications into the prescribing process. Am J Heal Pharm. 2018;75(11):774–783. https://doi.org/10.2146/ajhp170346.
- Institute of Medicine. Shaping the future: crossing the quality chasm: a new health system for the 21th century. Iom. 2001;(March):1–8. https://doi.org/10.17226/10027.
- Flintoft V. #ConquerSilence to improve medication safety. Canadian Patient Safety Institute. https://www.patientsafetyinstitute.ca/en/NewsAlerts/News/Pages/ConquerSilence-to-improve-medication-safety-2019-10.aspx. Published 2019. Accessed February 19 2020.
- Canadian Patient Safety Institute. Preventable Healthcare Harm | #ConquerSilence. https://conquersilence.ca/. Published 2019. Accessed February 19 2020.
- Canadian Patient Safety Institute. Five questions to ask about your medications. https://www.patientsafetyinstitute.ca/en/toolsResources/5-Questions-to-Ask-about-your-Medications/Pages/default.aspx. Published 2016. Accessed February 19 2020.
- Institute for Safe Medication Practices (ISMP). ISMP Guidelines for Standard Order Sets. 2010. https://www.ismp.org/guidelines/standard-order-sets.
- Institute for Safe Medication Practices (ISMP). Call to Action: Longstanding Strategies to Prevent Accidental Daily Methotrexate Dosing Must Be Implemented | Institute For Safe Medication Practices. Retrieved February 19, 2020, from https://www.ismp.org/resources/call-action-longstanding-strategies-prevent-accidental-daily-methotrexate-dosing-must-be.
- Institute for Safe Medication Practices (ISMP). Errors associated with oxytocin use: a multi-organization analysis by ISMP and ISMP Canada. https://www.ismp.org/resources/errors-associated-oxytocin-use-multi-organization-analysis-ismp-and-ismp-canada. Published 2020. Accessed February 19 2020.
- Bosch-Lenders D, Maessen DW, Stoffers HE, Knottnerus JA, Winkens B, van den Akker M. Factors associated with appropriate knowledge of the indications for prescribed drugs among community-dwelling older patients with polypharmacy. Age Ageing. 2016;45(3):402–408. https://doi.org/10.1093/ageing/afw045.
- Schiff G, Mirica MM, Dhavle AA, Galanter WL, Lambert B, Wright A. A Prescription For enhancing electronic prescribing safety. Health Aff. 2018;37(11):1877–1883. https://doi.org/10.1377/hlthaff.2018.0725.
- Garabedian PM, Wright A, Newbury I, et al. Comparison of a prototype for indications-based prescribing with 2 commercial prescribing systems. JAMA Netw Open. 2019;2(3):e191514–e191511.
- Greenhalgh T. How to implement evidence-based healthcare; 2018.